22 Nov 2018
AFT Pharmaceuticals narrows half-year loss by 98 percent
AFT Pharmacuetical's half-year loss has narrowed after it cut its research and development spending.
AFT Pharmacuetical's half-year loss has narrowed after it cut its research and development spending.